CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...